SynthesisFrontiers in psychology2025
Risk factors of mild behavioral impairment: a systematic review.
Synthesis in Frontiers in psychology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Article
- Reframing Dementia Prevention Strategies Aligned with the WHO Global Action Plan: A Structured Narrative Review Focusing on Mild Behavioral Impairment.Neurology international · 2026Review
- Alteration of glucose neurometabolism and brain morphology in mild behavioral impairment: a neuroimaging study on cognitively healthy individuals.Alzheimer's & dementia (Amsterdam, Netherlands)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Mild Behavioral Impairment (MBI) represents a predementia syndrome marked by neuropsychiatric symptoms that may precede detectable cognitive decline. Identifying factors associated with MBI is critical for developing targeted prevention strategies in neurodegenerative disorders. Methods: This systematic review adhered to PRISMA 2020 guidelines, searching PubMed, Scopus, Web of Science, ScienceDirect, and Embase through May 2024. Forty-one human studies meeting predefined inclusion criteria were selected through dual independent screening. Results: Five key domains emerged: (1) Genetic susceptibility (APOE ε4 allele showing strongest association), (2) Motor system pathology (particularly Parkinsonian features), (3) Multisensory deficits (auditory impairment demonstrating bidirectional relationships), (4) Metabolic dysregulation (diabetes mellitus and frailty phenotypes), and (5) Neuroanatomical correlates (frontolimbic atrophy patterns on MRI). The interaction between genetic predisposition and environmental/lifestyle factors appears central to MBI pathogenesis. Conclusion: MBI manifests as a multidimensional interface between molecular mechanisms and clinical phenomenology. Our synthesis supports the implementation of transdiagnostic screening protocols integrating behavioral biomarkers with conventional cognitive assessments. Future research should prioritize longitudinal designs to establish causal pathways and intervention thresholds.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.